Ice Immersion Using Virtual Reality & Augmented Reality

Sponsor
Stanford University (Other)
Overall Status
Completed
CT.gov ID
NCT04196686
Collaborator
(none)
185
1
2
19.4
9.6

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effectiveness of different technologies, Virtual Reality and Augmented Reality with modifications as passive content, active content, cognitive load modulation, and positive encouragement coaching to increase the pain threshold as assessed by immersing a hand in ice water.

Condition or Disease Intervention/Treatment Phase
  • Device: VR/AR
  • Other: Ice Bath
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
185 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Evaluating the Effectiveness of Immersive Technologies, Virtual Reality and Augmented Reality, to Increase Pain Threshold During Ice Immersion.
Actual Study Start Date :
Jul 24, 2019
Actual Primary Completion Date :
Mar 4, 2021
Actual Study Completion Date :
Mar 4, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ice bath Control then VR/AR

Participants will be randomized with a 1:1 allocation to use their dominant or non-dominant hand with VR or control (no VR) for the cold pressor test and then crossed over. Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.

Device: VR/AR
VR/AR headset with either passive or active content such as playing a game or watching a movie

Other: Ice Bath
Participants immerse hand in ice bath and starting again with their original assigned group and keep hand submerged as long as they can withstand the cold or until 4 minutes have elapsed, whichever comes first. Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.

Experimental: Ice bath with VR/AR then Control

Participants will be randomized with a 1:1 allocation to use their dominant or non-dominant hand with VR or control (no VR) for the cold pressor test and then crossed over. Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.

Device: VR/AR
VR/AR headset with either passive or active content such as playing a game or watching a movie

Other: Ice Bath
Participants immerse hand in ice bath and starting again with their original assigned group and keep hand submerged as long as they can withstand the cold or until 4 minutes have elapsed, whichever comes first. Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.

Outcome Measures

Primary Outcome Measures

  1. VR Effect on Pain Tolerence [Duration of ice bath (approximately 0 - 4 minutes)]

    Given that the cold pressor test produces an uncomfortable experience, we considered longer duration within the ice bath to represent increased pain tolerance. Measured in seconds (s).

Secondary Outcome Measures

  1. VR's Effect on Perceived Pain Intensity [Duration of ice bath (approximately 0 - 4 minutes)]

    During ice bath data collection participants will be asked to report pain on a numeric rating scale from 0-10, 0 being no pain and 10 being most excruciating pain imaginable every 30 seconds during ice bath

  2. Skin Conductance Response Density (SCRD) [Duration of ice bath (approximately 0 - 4 minutes)]

    The effects of VR on modulating sympathetic response in the presence of painful stimuli, was assessed by analyzing SCRD per 30 second interval. We refer to each of these 30 second intervals as a separate epoch. Skin conductance is expected to increase with increasing sympathetic nervous system activity, as sympathetic activity increases sweat secretion to increase skin conductance.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Greater than 18 years of age

  • English speaking

  • Hearing intact

Exclusion Criteria:
  • Patients who do not consent

  • Currently taking beta blockers or other chronotropic heart medication(s)

  • Have a history of severe motion sickness

  • Currently have nausea

  • Currently experiencing seizures

  • Are clinically unstable

  • Have taken pain medications in the last 12 hours

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Samuel Rodriguez, Clinical Associate Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT04196686
Other Study ID Numbers:
  • 50951
First Posted:
Dec 12, 2019
Last Update Posted:
Mar 25, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Samuel Rodriguez, Clinical Associate Professor, Stanford University
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail 185 participants signed informed consent, 156 participants were allocated to a study arm
Arm/Group Title Ice Bath Control Then VR/AR Ice Bath With VR/AR Then Control
Arm/Group Description Participants placed their dominant or non-dominant hand in ice bath without the use of Virtual Reality (VR)/Augmented Reality (AR), then crossed to place their opposite hand in ice bath with the use of VR/AR Participants placed their dominant or non-dominant hand in ice bath with the use of Virtual Reality (VR)/Augmented Reality (AR), then crossed to place their opposite hand in ice bath without the use of VR/AR
Period Title: First Treatment (4 Minutes)
STARTED 78 78
COMPLETED 78 75
NOT COMPLETED 0 3
Period Title: First Treatment (4 Minutes)
STARTED 78 75
COMPLETED 78 75
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title All Participants
Arm/Group Description Participants placed their dominant or non-dominant hand in ice bath with or without the use of VR/AR, then crossed to place their opposite hand in ice bath using the opposite treatment or control
Overall Participants 153
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
29.10
(9.83)
Sex: Female, Male (Count of Participants)
Female
84
54.9%
Male
69
45.1%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
26
17%
Not Hispanic or Latino
108
70.6%
Unknown or Not Reported
19
12.4%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
1
0.7%
Asian
49
32%
Native Hawaiian or Other Pacific Islander
1
0.7%
Black or African American
2
1.3%
White
69
45.1%
More than one race
12
7.8%
Unknown or Not Reported
19
12.4%
Region of Enrollment (Count of Participants)
United States
153
100%
First hand assignment (Count of Participants)
Dominant
73
47.7%
Non-Dominant
80
52.3%
VR hand assignment (Count of Participants)
Dominant
83
54.2%
Non-Dominant
70
45.8%

Outcome Measures

1. Primary Outcome
Title VR Effect on Pain Tolerence
Description Given that the cold pressor test produces an uncomfortable experience, we considered longer duration within the ice bath to represent increased pain tolerance. Measured in seconds (s).
Time Frame Duration of ice bath (approximately 0 - 4 minutes)

Outcome Measure Data

Analysis Population Description
Participants who complete the respective interventions are included in the analysis.
Arm/Group Title Ice Bath Control Ice Bath With VR/AR
Arm/Group Description Participants placed their dominant or non-dominant hand in ice bath without the use of VR/AR Participants placed their dominant or non-dominant hand in ice bath with the use of VR/AR
Measure Participants 156 153
Mean (Standard Deviation) [seconds]
135
(92)
158
(89)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Ice Bath Control, Ice Bath With VR/AR
Comments
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value <0.001
Comments
Method Cox mixed effects model
Comments
Method of Estimation Estimation Parameter Hazard Ratio (HR)
Estimated Value 0.36
Confidence Interval (2-Sided) 95%
0.25 to 0.51
Parameter Dispersion Type:
Value:
Estimation Comments
2. Secondary Outcome
Title VR's Effect on Perceived Pain Intensity
Description During ice bath data collection participants will be asked to report pain on a numeric rating scale from 0-10, 0 being no pain and 10 being most excruciating pain imaginable every 30 seconds during ice bath
Time Frame Duration of ice bath (approximately 0 - 4 minutes)

Outcome Measure Data

Analysis Population Description
Participants who complete the respective interventions are included in the analysis.
Arm/Group Title Ice Bath Control Ice Bath With VR/AR
Arm/Group Description Participants placed their dominant or non-dominant hand in ice bath without the use of VR/AR Participants placed their dominant or non-dominant hand in ice bath with the use of VR/AR
Measure Participants 156 153
0 seconds
2.1
(1.3)
2.0
(1.3)
30 seconds
4.9
(2.1)
4.4
(2.1)
60 seconds
6.0
(1.9)
5.5
(2.0)
90 seconds
6.2
(2.0)
5.9
(2.1)
120 seconds
6.0
(2.0)
5.7
(2.0)
150 seconds
5.9
(2.0)
5.5
(2.3)
180 seconds
5.6
(2.1)
5.3
(2.4)
210 seconds
5.5
(2.3)
5.1
(2.5)
240 seconds
5.2
(2.3)
5.0
(2.6)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Ice Bath Control, Ice Bath With VR/AR
Comments Analysis was controlled for dominant hand treatment assignment, dominant hand order, and gender. Overall mean difference calculated from regression model.
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value 0.200
Comments
Method Linear mixed effects model
Comments
Method of Estimation Estimation Parameter Mean Difference (Net)
Estimated Value 0.455
Confidence Interval (2-Sided) 95%
0.32 to 0.59
Parameter Dispersion Type:
Value:
Estimation Comments
3. Secondary Outcome
Title Skin Conductance Response Density (SCRD)
Description The effects of VR on modulating sympathetic response in the presence of painful stimuli, was assessed by analyzing SCRD per 30 second interval. We refer to each of these 30 second intervals as a separate epoch. Skin conductance is expected to increase with increasing sympathetic nervous system activity, as sympathetic activity increases sweat secretion to increase skin conductance.
Time Frame Duration of ice bath (approximately 0 - 4 minutes)

Outcome Measure Data

Analysis Population Description
Participants who complete the respective interventions are included in the analysis.
Arm/Group Title Ice Bath Control Ice Bath With VR/AR
Arm/Group Description Participants placed their dominant or non-dominant hand in ice bath without the use of VR/AR Participants placed their dominant or non-dominant hand in ice bath with the use of VR/AR
Measure Participants 156 153
Mean (Standard Deviation) [microsiemens]
0.10
(0.069)
0.09
(0.061)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection Ice Bath Control, Ice Bath With VR/AR
Comments The variables in the physiologic model were SCRD change over time and the SCRD change between groups, defined as those with and without VR.
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value 0.047
Comments
Method Linear mixed effects model
Comments
Method of Estimation Estimation Parameter Mean Difference (Net)
Estimated Value 0.002
Confidence Interval (2-Sided) 95%
0.00007 to 0.00368
Parameter Dispersion Type:
Value:
Estimation Comments

Adverse Events

Time Frame 1 day
Adverse Event Reporting Description
Arm/Group Title Ice Bath Control Ice Bath With VR/AR
Arm/Group Description Participants placed their dominant or non-dominant hand in ice bath without the use of VR/AR Participants placed their dominant or non-dominant hand in ice bath with the use of VR/AR
All Cause Mortality
Ice Bath Control Ice Bath With VR/AR
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/156 (0%) 0/153 (0%)
Serious Adverse Events
Ice Bath Control Ice Bath With VR/AR
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/156 (0%) 0/153 (0%)
Other (Not Including Serious) Adverse Events
Ice Bath Control Ice Bath With VR/AR
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/156 (0%) 0/153 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Samuel Rodriguez, MD
Organization Lucile Packard Children's Hospital Stanford
Phone (650)723-6412
Email sr1@stanford.edu
Responsible Party:
Samuel Rodriguez, Clinical Associate Professor, Stanford University
ClinicalTrials.gov Identifier:
NCT04196686
Other Study ID Numbers:
  • 50951
First Posted:
Dec 12, 2019
Last Update Posted:
Mar 25, 2022
Last Verified:
Feb 1, 2022